Brandon Capital, Yuuwa Capital lead funding round for PolyActiva
21st Feb 13
Early stage company PolyActiva has received A$9.2m in funding thanks to a Series B fundraising round led by a consortium of investors including Brandon Capital and Yuuwa Capital. The Australian biotech firm said the funds will help further the preclinical and clinical development programs of its products under development. Funding came from angel investors, Yuuwa and Brandon's Medical Research Commercialisation Fund and Brandon Biosciences Fund 1.